Can peptides be taken orally? Pills vs shots

A few peptide pills are approved

Semaglutide pills are approved. BPC-157 pills, sprays and creams are not proven.

By the Peptide Science Desk Editorial TeamFact-checked against FDA and official sources · Not yet reviewed by a licensed clinician. How we check facts

Short answer: Some can, but most cannot. The gut breaks down most peptides, like protein in food. Semaglutide pills (Rybelsus, Ozempic tablets, Wegovy tablets) are FDA approved because they use a helper ingredient called SNAC. Even so, the label says only about 1% to 2% of a Wegovy pill gets into the blood, vs 89% from the shot. Pills, sprays and creams of BPC-157 and other online peptides are not proven. New to peptides? Start here: what are peptides?
Two scientists in lab coats look closely at a small glass vial
Two scientists check a vial in a National Cancer Institute lab (2000 photo).Photo: Bill Branson, National Cancer Institute (NIH), public domain

Can peptides be taken orally?

  • A few can. Peptides are small proteins. Like protein in food, most get broken down in the gut before they reach the blood.
  • Semaglutide pills work because they contain SNAC, an ingredient that helps the drug get absorbed in the stomach, say their FDA labels.
  • Other FDA-approved peptide pills exist for rare uses: octreotide capsules (Mycapssa) for acromegaly, and desmopressin tablets (DDAVP) for a type of diabetes insipidus.
  • Linzess (linaclotide) is a peptide pill for constipation. Its label says it is barely absorbed. It works inside the gut.

Do oral peptides work as well as injections?

  • For semaglutide, the pill and the shot both work in big trials. But the trials were separate, so they cannot be compared fairly.
  • Shot: in STEP 1, people lost about 14.9% of their weight in 68 weeks, vs 2.4% on placebo.
  • Pill: in OASIS 4, people on the daily semaglutide pill lost about 13.6% in 64 weeks, vs 2.2% on placebo.
  • The Wegovy pill is taken every day. The Wegovy shot is taken once a week.
  • The pill has strict rules on its label: take it on an empty stomach in the morning with a little plain water, and wait at least 30 minutes before eating, drinking or other pills.

Is there a Zepbound or tirzepatide pill?

  • No. Every tirzepatide label we found in the FDA drug label database is a shot (checked October 22, 2026).
  • Lilly’s weight-loss pill is Foundayo (orforglipron). It works on the GLP-1 switch, but it is not a peptide. It is a small chemical.
  • In its big trial (ATTAIN-1), people on the top dose lost about 11.2% of their weight in 72 weeks, vs 2.1% on placebo.

Do BPC-157 capsules or oral BPC-157 work?

  • Nobody knows. BPC-157 is not FDA approved in any form.
  • A 2026 review found only 3 small studies of BPC-157 in people (30 people in total). None of them tested pills or capsules.
  • Claims about oral BPC-157 come from animal and lab studies. Those do not prove it works in people.
  • No data on pills also means no data on their safety. Unknown is not the same as safe.

Do peptide nasal sprays work?

  • One kind is FDA approved: desmopressin nasal spray, for central diabetes insipidus.
  • Selank and Semax nasal sprays are not FDA approved. The FDA says there is little or no safety data for Semax.
  • Bremelanotide (PT-141) was tested as a nasal spray in one label study, but the approved Vyleesi is a shot.
  • A spray that is not approved has no FDA check of what is inside or how much.

Do peptide creams or GLP-1 patches work?

  • Skin creams with peptides are usually sold as cosmetics. The FDA says cosmetics do not need FDA approval before sale.
  • The FDA says a product that claims to regrow hair or "regenerate cells" is a drug under the law, even if it is sold as a cosmetic.
  • GLP-1 patches: every semaglutide and tirzepatide label we found in the FDA database is a shot or a pill. We found no approved patch.
  • On March 31, 2026, the FDA sent a warning letter to an online seller of a "GLP-1" microneedle patch. It said the patch was an unapproved new drug.

Are peptide pills safer than shots?

  • Not clearly. The Wegovy pill and shot share the same label warnings.
  • Pills still cause stomach side effects. In OASIS 1, 80% of people on a semaglutide pill had stomach side effects, vs 46% on placebo. They were mostly mild to medium.
  • Shots can cause skin reactions where you inject. Labels say never share a pen, even with a new needle.
  • The semaglutide pill labels say breastfeeding is not recommended, because SNAC could build up in babies.
  • How well it works, how safe it is, and FDA status are separate questions.

The numbers in charts

Weight loss: GLP-1 pills vs the shot

% of starting body weight lost, drug vs placebo (fake medicine)

Different trials, different people: not a head-to-head comparison.

Show the numbers as a table
Weight loss: GLP-1 pills vs the shot: % of starting body weight lost, drug vs placebo (fake medicine)
TrialDrugPlacebo
Semaglutide shot 2.4 mg (Wegovy)
STEP 1 · 1,961 adults · 68 weeks
−14.9%−2.4%
Semaglutide pill 25 mg (Wegovy tablets)
OASIS 4 · 307 adults · 64 weeks
−13.6%−2.2%
Semaglutide pill 50 mg
OASIS 1 · 667 adults · 68 weeks · this dose is not sold
−15.1%−2.4%
Orforglipron pill 36 mg (Foundayo) (Not a peptide)
ATTAIN-1 · 3,127 adults · 72 weeks
−11.2%−2.1%
Orforglipron is a small-molecule pill, not a peptide. It is shown because people compare it with peptide GLP-1 drugs. The OASIS and ATTAIN trials were paid for by the drug makers (Novo Nordisk and Eli Lilly). Sources: Wilding et al., NEJM 2021 (STEP 1) (PMID 33567185); Knop et al., Lancet 2023 (OASIS 1) (PMID 37385278); Wharton et al., NEJM 2025 (OASIS 4) (PMID 40934115); Wharton et al., NEJM 2025 (ATTAIN-1) (PMID 40960239).

How much of the dose reaches your blood

Share of semaglutide that gets into the blood (bioavailability), shot vs pill

Most of a peptide pill is broken down in the gut. That is why the pill dose is much bigger than the shot dose.

Show the numbers as a table
How much of the dose reaches your blood: Share of semaglutide that gets into the blood (bioavailability), shot vs pill
FormReaches the blood
Semaglutide shot (Wegovy)
Under the skin
89%
Wegovy tablets
Swallowed pill
about 1–2%
Rybelsus tablets
Swallowed pill (diabetes)
about 0.4–1%
Numbers from section 12.3 (how the body handles the drug) of each FDA label. Sources: Wegovy FDA label, sections 6.1 and 12.3 (DailyMed); Rybelsus FDA label, section 12.3 (DailyMed).

Stomach side effects on semaglutide pills

% of adults with any stomach or gut side effect (like nausea or diarrhea)

Many people on placebo also had stomach problems. Most were mild to moderate.

Show the numbers as a table
Stomach side effects on semaglutide pills: % of adults with any stomach or gut side effect (like nausea or diarrhea)
TrialSemaglutide pillPlacebo
OASIS 1 (50 mg pill)
667 adults · 68 weeks
80%46%
OASIS 4 (25 mg pill, Wegovy tablets)
307 adults · 64 weeks
74.0%42.2%
Two separate trials. Paid for by Novo Nordisk, which makes semaglutide. Sources: Knop et al., Lancet 2023 (OASIS 1) (PMID 37385278); Wharton et al., NEJM 2025 (OASIS 4) (PMID 40934115).

More charts: Peptides by the numbers

Studies in people

Big trials of shots and pills. They were separate trials, so their numbers are not a head-to-head test.

Study typePeopleMain findingLimits
Randomized trial: weekly semaglutide shot vs placebo (STEP 1), 20211,961 adults with obesity or overweightWeight went down 14.9% vs 2.4% in 68 weeksDifferent people and length than the pill trials
Randomized trial: daily semaglutide pill vs placebo (OASIS 4), 2025307 adults with obesity or overweightWeight went down 13.6% vs 2.2% in 64 weeksSmall trial; 4 countries
Randomized trial: higher-strength semaglutide pill vs placebo (OASIS 1), 2023667 adults with obesity or overweightWeight went down 15.1% vs 2.4% in 68 weeks; stomach side effects in 80% vs 46%This strength is not the approved one
Randomized trial: orforglipron pill (Foundayo) vs placebo (ATTAIN-1), 20253,127 adults with obesityWeight went down 11.2% (top dose) vs 2.1% in 72 weeksNot a peptide
Review of all human studies: BPC-157, 20263 small studies, 30 people in totalNo study tested pills or capsulesPoor-quality studies

Pills, shots and sprays at a glance

Wegovy / Ozempic shot (semaglutide)Wegovy tablets / Rybelsus (semaglutide pill)Foundayo pill (orforglipron)BPC-157 pills or sprays
Is it a peptide?YesYesNo (small chemical)Yes
FDA statusApprovedApprovedApproved for weightNot approved
How much gets into the blood (label)89%About 1% to 2% (Wegovy and Ozempic tablets)Not listed this wayUnknown
Proof it works in peopleStrongStrongStrongNone for pills or sprays
Safety dataWell studiedWell studiedStudied (newer drug)Very little
Check any peptide in 1 secondFree FDA Status Checker: approved, being tested, or not proven.

FAQ

Is the Wegovy pill the same medicine as the Wegovy shot?

It is the same active drug, semaglutide, in a different form. The label says not to use it with other semaglutide products or other GLP-1 drugs.

Why can I not crush or split the semaglutide pill?

The Wegovy label says to swallow the tablets whole and not split, crush, chew or dissolve them. Ask your pharmacist why this matters for your pill.

Can I swallow a peptide that was made for injection?

Do not do this. There are no studies showing it works or is safe, and products sold "for research" are not checked by the FDA.

Are under-the-tongue peptides proven?

We found no FDA-approved under-the-tongue form of semaglutide, tirzepatide or BPC-157. Ask your doctor before trying one.

Does insurance cover the pill or the shot?

It depends on your plan. Ask your plan or pharmacist. We do not list prices.

Is a nasal spray faster than a shot?

It depends on the drug. For the peptides sold online as sprays, no good human studies tell us.

Related pages

We never share doses or tell you where to buy. Always ask your doctor. Print our doctor questions sheet.

Sources

Not medical advice. Medical disclaimer.